您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > CGP 36216 hydrochloride
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
CGP 36216 hydrochloride
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
CGP 36216 hydrochloride图片
CAS NO:123691-29-2
包装与价格:
包装价格(元)
1mg电议
5mg电议
10mg电议

产品介绍
Selective GABAB antagonist
Cas No.123691-29-2
化学名(3-aminopropyl)(ethyl)phosphinic acid hydrochloride
Canonical SMILESCCP(CCCN)(O)=O.Cl
分子式C5H14NO2P.HCl
分子量187.6
溶解度<18.76mg/ml in DMSO;<18.76mg/ml in Water
储存条件Desiccate at RT
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
产品描述

CGP 36216 hydrochloride is a potent and selective antagonist of GABAB receptors with IC50 value of 43 μM.

GABAB receptors (GABABR) are metabotropic transmembrane receptors for gamma-aminobutyric acid (GABA) and are linked through G-proteins to potassium channels. Expression of GABAB receptors are found in the central as well as in the autonomic division of the peripheral nervous system. GABAB receptors play a key role in regulating membrane excitability and synaptic transmission in the brain.

In rat neocortical preparations maintained in Mg2+-free Krebs medium, CGP 36216 acts as antagonism of baclofen-induced suppression of spontaneous discharges in a concentration-dependent manner. However, CGP 36216, up to 1 mM, was ineffective in antagonising baclofen-induced hyperpolarisations, mediated through gamma-aminobutyric acid (B) GABAB postsynaptic receptors 1.

In electrically stimulated brain slices preloaded with [3H] GABA, CGP 36216 increased the release of [3H] GABA, that was reversed by baclofen. While CGP 36216 is ineffective at GABAB postsynaptic receptors, it is appreciably more active at presynaptic receptors1.

Reference:
1.   Ong J, Bexis S, Marino V, et al. CGP 36216 is a selective antagonist at GABA(B) presynaptic receptors in rat brain. European journal of pharmacology. 2001;415(2-3):191-195.